Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Medistim ASA ( (DE:MD1) ).
Medistim ASA has called its Annual General Meeting for 6 May 2026 at the company’s headquarters in Oslo, inviting shareholders to participate in key corporate governance decisions. Shareholders can attend in person or exercise their rights remotely through proxies with or without voting instructions, reinforcing accessibility and engagement in the company’s decision-making process.
The notice underscores Medistim’s adherence to Norwegian securities disclosure requirements and formal procedures for investor communication. By facilitating flexible voting options and clear instructions, the company aims to maintain robust shareholder involvement as it continues to develop its niche ultrasound technology business for surgical applications worldwide.
More about Medistim ASA
Medistim ASA is a Norway-based medical technology company and niche leader in ultrasound solutions for cardiac, vascular and transplant surgery. Founded in 1984, it has a long track record of profitable growth and continues to invest in new product development, serving global markets through subsidiaries in major countries and a wide distributor network across Europe, Asia, the Middle East, Africa and the Americas.
Average Trading Volume: 30,919
Current Market Cap: NOK4.23B
Learn more about MD1 stock on TipRanks’ Stock Analysis page.